Navigation Links
DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product
Date:2/8/2011

development of state-of-the-art biodegradable, controlled-release injectable therapeutics.  The SABER technology is the basis of POSIDUR, which is in Phase III clinical trials in the U.S. and Phase II clinical trials in the E.U.  In addition, DURECT has a number of feasibility projects underway that utilize the SABER system for the delivery of various proteins and peptides for periods of up to one month from a single injection.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR™, and TRANSDUR®-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR™, SABER™, ORADUR®, TRANSDUR®, and ELADUR™ are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commercialization by the U.S. Food and Drug Administration or other health authorities.

About CreoSalus

CreoSalus is a privately held Louisville, Kentucky based life-sciences company specializing in the development and manufacturing of finished drugs, human medical devices, and fine chemicals.  The Company's three peptide-based businesses are Advanced ChemTech (fine chemicals), Occam Design (human medical devices), and Thorn BioScience (finished drugs).  Thorn BioScience's products include SucroMate™ Porcine (under development) and FDA approved Sucr
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DURECT to Present at the BIO CEO & Investor Conference
2. DURECT to Present at the Credit Suisse 2010 Healthcare Conference
3. DURECT Corporation Announces Third Quarter 2010 Financial Results
4. DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call
5. DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference
6. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
7. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
8. DURECT to Present at the Jefferies Global Life Sciences Conference
9. DURECT to Present at the Rodman & Renshaw Global Healthcare Conference
10. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
11. DURECT to Present at the Barclays Capital Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Aptuit LLC announces that Aptuit SSCI, ... , has enhanced its capabilities in the areas ... large molecules, including biologic drugs, metabolites, and polymers, ... mass spectrometer. In making the announcement, ... "The expanded large molecule capability enhances our early ...
(Date:8/21/2014)... Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... cancers and women,s health, has appointed Holly B. ... Markets. Ms. Bauzon has a proven track ... coverage for laboratory services companies. She has more than ... Inc., where she held the position of Director, Lab ...
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... , FORT COLLINS, Colo., Dec. 14 Manchester Pharmaceuticals, ... (chenodiol tablets). On October 22, 2009, the US ... therapy for patients suffering from gallstones in whom surgery ... advanced age. , Chenodal prescriptions have started to be ...
... 14 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today ... the addition of Lt. Gen. Ronald R. Blanck, DO, U.S. ... Associates, a federal health services consulting firm based in Falls ... nine members. , Dr. Blanck began his military career in ...
Cached Medicine Technology:Manchester Announces Availability of Chenodal(TM) 2Oxygen Biotherapeutics, Inc. Expands Board of Directors 2
(Date:8/23/2014)... Pixel Film Studios, a leader of Final Cut Pro ... Vol.3, a customizable title tool for FCPX , ... dragging ProIntro Vol.3 in their timeline" says Christina Austin, CEO ... saver and i think our users will agree" , ProIntro ... made with Final Cut Pro X users in mind. Achieve ...
(Date:8/23/2014)... 23, 2014 Youth substance abuse is ... no different in Houston, TX. Substance abuse can happen ... to drug and alcohol dependency in higher numbers than ... beat substance abuse, but don’t know where to find ... can be a challenge because most treatment options are ...
(Date:8/23/2014)... 2014 Summer vacation is almost over and ... in session. While shopping for school supplies and a new ... encourages parents and students to also spend some time brushing ... excellent hitchhikers and thrive in heavily populated places,” said Randy ... and dorms the perfect settings for bed bugs to take ...
(Date:8/22/2014)... August 23, 2014 2014 Deep ... a professional and in-depth research report on the ... Meter information, including Glucose Meter definition, classification, application, ... overview. This research covers the international market analysis, ... analysis covering macroeconomic environment & economic situation analysis. ...
(Date:8/22/2014)... Today, Zane Benefits, the #1 Online Health ... Plans. , According to Zane Benefits, employers are adopting ... the cost of healthcare without reducing coverage for employees. ... can be confusing. , The new guide contains a ... types of ABHPs. It also explains the similarities, ...
Breaking Medicine News(10 mins):Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3
... News) -- "Team-based care" should be used to improve ... Community Preventive Services recommended on Tuesday. The recommendation ... showed improvements in patients, control of blood pressure when ... -- a primary care doctor supported by a pharmacist, ...
... who undergo one of the most common treatments for ... according to new research by Henry Ford Hospital. ... level of the surgeon doing the procedure mattered somewhat ... on data gathered throughout the U.S., will be presented ...
... Rice University freshmen took a mousetrap and built a better ... "The goal was to regulate the amount of fluid ... said Melissa Yuan, a member of the IV DRIP (Dehydrated ... designed to be used in severely underdeveloped parts of the ...
... HealthDay Reporter , TUESDAY, May 15 (HealthDay News) ... arteries, it may not be useful to give them ... symptoms such as chest pain or shortness of breath, ... populations of post-angioplasty and post-bypass patients; screening asymptomatic patients ...
... 15, 2012) - Beta-carotene, selenium and folic acid taken ... are probably harmless. But taken at much higher levels as ... proven to increase the risk of developing a host of ... they,re essential and we need them, but we need them ...
... recent research released in June,s Journal of Thoracic Oncology ... the lungs might be an additional predictive technique for lung ... found that 96.4 percent of the positive CT screening results ... more accurately diagnose patients. This research focused on a way ...
Cached Medicine News:Health News:U.S. Task Force Issues Blood Pressure Guidelines 2Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2Health News:This 'mousetrap' may save lives 2Health News:Are Post-Angioplasty Stress Tests Unnecessary? 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: